摘要Delta like non-canonical Notch ligand 1(DLK1),as a member of epidermal growth factor-like family,plays a critical role in somatic growth,tissue development and possibly tissue renewal.Though previous studies had indicated that DLK1 contributed to adipogenesis and myogenesis,it's still controversial whether DLK1 affects angiogenesis and how it interacts with Notch signaling with numerous conflicting reports from different models.Based on our preliminary finding that DLK1 expression was up-regulated in mice ischemic gastrocnemius and in the border zone of infarcted myocardium,we administered either recombinant DLK1(rDLK1)or PBS in C57BL/6 mice after establishment of hindlimb ischemia(HLI)and myocardial infarction(MI),respectively.Exogenous rDLK1 administration significantly improved both blood perfusion of mice ischemic hindlimbs and muscle motor function on the 3rd,7th day after HLI,by promoting neovascularization.Similar effect on neovascularization was verified in mice on the 28th day after Ml as well as improvement of cardiac failure.Correspondingly,the number of CD34+KDR+cells,indicated as endothelial progenitor cells(EPCs),was significantly in mice ischemic gastrocnemius by rDLK1 administration,which was abrogated by DAPT as the specific inhibitor of Notch intracellular domain(NICD).Furthermore,bone marrow mononuclear cells were obtained from C57BL/6 mice and differentiated to EPCs ex vivo.Incubation with rDLK1 triggered Notch1 mRNA and NICD protein expressions in EPCs as exposed to hypoxia and serum deprivation,promoting EPCs proliferation,migration,anti-apoptosis and tube formation.Otherwise,rDLK1 incubation significantly decreased intracellular and mitochondrial reactive oxygen species,increased ATP content and mitochondrial membrane potential,downregulated short isoform of OPA-1 expression whereas upregulated mitofusin(-1,-2)expression in EPCs by Notch1 signaling,which were all abrogated by DAPT.In summary,the present study unveils the pro-angiogenesis and its mechanism of rDLK1 through activation of Notch1 signaling in endothelial progenitor cells.